- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02965534
Evaluation of a Night Spectacle Correction Concerning an Improvement of Mesopic Vision Quality
Reduced quality of vision and glare in twilight or night are frequently mentioned complaints within the optometric examination. A reason for these problems could be a myopic refractive shift in dark light conditions, commonly known as night myopia or twilight myopia.
The aim of this study was to investigate whether quality of vision in twilight or night could be improved by a spectacle correction optimized for mesopic light conditions. Moreover, objective refraction in large pupils measured by aberrometry was compared to subjective mesopic refraction.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
After obtaining informed consent, aberrometry was performed in a darkened room (0.1 lux). Subjective photopic refraction and visual acuity were measured before light was turned off and mesopic refraction was obtained after a dark adaptation period of five minutes. Finally, frames and lenses were fitted by a centration system. Lens grinding was executed centralized by a grinding workshop. In the course of this study, subjects were randomly assigned to wear two glasses double-masked in turn. One with photopic subjective refraction data and another with mesopic subjective refraction data. Both were worn for 14 ± 2 days each.
Follow Up 1:
After two weeks, participants were asked for their subjective experiences with the first correction by a visual analogue scale questionnaire. After the evaluation, glasses were changed.
Follow Up 2:
Two weeks later, subjective experiences were evaluated again. After visual analogue scale questionnaire, subjects were asked to compare the two glasses concerning quality of mesopic vision and subjective safety level during night driving.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Bavaria
-
Augsburg, Bavaria, Germany
- Degle Optometry
-
Klingenberg am Main, Bavaria, Germany, 63911
- Hessler Optometry
-
-
TH
-
Jena, TH, Germany, 07745
- University of applied sciences
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Visual Acuity at least 0.8 (5/6)
- Binocular Vision
Exclusion Criteria:
- refraction more than sph +/- 6 D and cyl 2 D
- Difference between habitual correction and actual refraction more than 0.5 D
- Medication with an influence on visual system
- Disease or eye disease with an effect on the visual system
- pregnancy or other hormonal variances
- influence of drugs
- mental handicap
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Triple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Night Spectacle Correction
Refraction for this glasses was obtained at low luminance.
|
|
Active Comparator: Spectacle Correction for photopic light conditions
Refraction for this glasses was obtained at high luminance level.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Night Myopia
Time Frame: Baseline only
|
Value of refractive shift (SE) when changing luminance from a photopic to a mesopic level. At Baseline, participants were not separated into arms as the Randomization Process was carried out at a later time point after participants picked up study glasses. Therefore, data are presented for All Participants in one Arm/Group. |
Baseline only
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Mesopic Visual Acuity Improvement
Time Frame: Baseline only
|
Difference of visual acuity (monocular and binocular) in a darkened room (0.1 lux) after a dark adaption period of 5 min. with photopic spectacle correction ("classic" refraction obtained in photopic light conditions) compared to mesopic spectacle correction (correction of night myopia) Scale: logMAR visual acuity, using Landolt C optotypes. At Baseline, participants were not separated into arms as the Randomization Process was carried out at a later time point after participants picked up study glasses. Therefore, data are presented for All Participants in one Arm/Group. |
Baseline only
|
Subjective Vision Comfort in Dark Light Conditions
Time Frame: Test Period (4 weeks)
|
Evaluation of subjective perceived vision comfort with the study and control glasses. Both glasses (study and control glasses) were tested for two weeks each. After the two weeks test, each of the glasses was evaluated. For evaluation a visual analogue scale questionnaire (Scale 0 - 100) was used. Question: How would you evaluate vision comfort with the tested glasses in dark light conditions? Answer: visual analogue scale slider from 0 (insufficient) to 100 (very good) |
Test Period (4 weeks)
|
Subjective Vision Sharpness in Dark Light Conditions
Time Frame: Test Period (4 weeks)
|
Evaluation of subjective perceived vision sharpness with the study and control glasses. Both glasses (study and control glasses) were tested for two weeks each. After the two weeks test, each of the glasses was evaluated. For evaluation a visual analogue scale questionnaire (Scale 0 - 100) was used. Question: How would you evaluate vision sharpness with the tested glasses in dark light conditions? Answer: visual analogue scale slider from 0 (insufficient) to 100 (very good) |
Test Period (4 weeks)
|
Subjective Glare Sensitivity in Dark Light Conditions
Time Frame: Test Period (4 weeks)
|
Evaluation of subjective perceived glare sensitivity with the study and control glasses. Both glasses (study and control glasses) were tested for two weeks each. After the two weeks test, each of the glasses was evaluated. For evaluation a visual analogue scale questionnaire (Scale 0 - 100) was used. Question: How would you evaluate glare sensitivity with the tested glasses in dark light conditions? Answer: visual analogue scale slider from 0 (no glare) to 100 (strong glare) |
Test Period (4 weeks)
|
Subjective Driving Safety in Dark Light Conditions
Time Frame: Test Period (4 weeks)
|
Evaluation of subjective perceived driving safety sense with the study and control glasses. Both glasses (study and control glasses) were tested for two weeks each. After the two weeks test, each of the glasses was evaluated. For evaluation a visual analogue scale questionnaire (Scale 0 - 100) was used. Question: How would you evaluate driving safety sense when driving in twilight or night with the tested glasses? Answer: visual analogue scale slider from 0 (not safe) to 100 (very safe) |
Test Period (4 weeks)
|
Collaborators and Investigators
Collaborators
Investigators
- Principal Investigator: Stephan Degle, Prof., University of Applied Sciences Jena
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- IGAMYO
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Myopia-Night Blindness
-
Direction Centrale du Service de Santé des ArméesCompleted
-
Ocuphire Pharma, Inc.Viatris Inc.RecruitingMesopic Vision | Night Vision LossUnited States
-
Sheba Medical CenterCompleted
-
University of New MexicoCompletedRetinitis Pigmentosa | Age Related Macular Degeneration | Congenital Stationary Night Blindness | ColorblindnessUnited States
-
University of Wisconsin, MadisonNational Institute of Health Research and Development, Ministry of Health...CompletedVitamin A DeficiencyUnited States, Indonesia
-
Tufts UniversityCompleted
-
Wageningen UniversityUniversity of Nairobi; European CommissionCompletedVitamin A DeficiencyKenya
-
Newcastle UniversityPenn State University; International Food Policy Research InstituteUnknownVitamin A DeficiencyUnited Kingdom
-
Wageningen UniversityUniversity of Ibadan; International Institute for Tropical AgricultureCompletedVitamin A DeficiencyNigeria
-
Johns Hopkins Bloomberg School of Public HealthUniversity of California, Davis; Newcastle University; HarvestPlusCompletedVitamin A DeficiencyZambia
Clinical Trials on Spectacle/Glasses
-
Beijing Tongren HospitalCompleted
-
University of MinnesotaInnovations for Poverty Action; Peek Vision; Vision ActionRecruiting
-
The Hong Kong Polytechnic UniversityProcornea Nederland B.V.Completed
-
SightGlass Vision, Inc.Active, not recruiting
-
SightGlass Vision, Inc.Active, not recruitingJuvenile MyopiaUnited States, Canada
-
SightGlass Vision, Inc.Active, not recruitingMyopia | Juvenile MyopiaUnited States, Canada
-
SightGlass Vision, Inc.CompletedMyopia | Myopia Progression | Juvenile MyopiaUnited States
-
Neurolens Inc.CompletedHeadache | Computer Vision Syndrome | Convergence Insufficiency | Binocular Vision DisorderUnited States
-
Johnson & Johnson Vision Care, Inc.CompletedPhotosensitivityUnited States
-
Neurolens Inc.TerminatedComputer Vision Syndrome | Convergence Insufficiency | Binocular Vision DisorderUnited States